• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶 A 的催化亚基对 Tau 蛋白的磷酸化和去磷酸化作用的电泳迁移率变化探测

Phosphorylation and Dephosphorylation of Tau Protein by the Catalytic Subunit of PKA, as Probed by Electrophoretic Mobility Retard.

机构信息

Departamento de Química Física Aplicada, Universidad Autónoma de Madrid, Madrid, Spain.

Centro de Biología Molecular Severo Ochoa, CSIC, Madrid, Spain.

出版信息

J Alzheimers Dis. 2021;79(3):1143-1156. doi: 10.3233/JAD-201077.

DOI:10.3233/JAD-201077
PMID:33386804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7990467/
Abstract

BACKGROUND

Tau is a microtubule associated protein that regulates the stability of microtubules and the microtubule-dependent axonal transport. Its hyperphosphorylated form is one of the hallmarks of Alzheimer's disease and other tauopathies and the major component of the paired helical filaments that form the abnormal proteinaceous tangles found in these neurodegenerative diseases. It is generally accepted that the phosphorylation extent of tau is the result of an equilibrium in the activity of protein kinases and phosphatases. Disruption of the balance between both types of enzyme activities has been assumed to be at the origin of tau hyperphosphorylation and the subsequent toxicity and progress of the disease.

OBJECTIVE

We explore the possibility that, beside the phosphatase action on phosphorylated tau, the catalytic subunit of PKA catalyzes both tau phosphorylation and also tau dephosphorylation, depending on the ATP/ADP ratio.

METHODS

We use the shift in the relative electrophoretic mobility suffered by different phosphorylated forms of tau, as a sensor of the catalytic action of the enzyme.

RESULTS

The results are in agreement with the long-known thermodynamic reversibility of the phosphorylation reaction (ATP + Protein = ADP+Phospho-Protein) catalyzed by PKA and many other protein kinases.

CONCLUSION

The results contribute to put the compartmentalized energy state of the neuron and the mitochondrial-functions disruption upstream of tau-related pathologies.

摘要

背景

Tau 是一种微管相关蛋白,可调节微管的稳定性和微管依赖性轴突运输。其过度磷酸化形式是阿尔茨海默病和其他 Tau 病的标志之一,也是形成这些神经退行性疾病中异常蛋白缠结的双螺旋丝的主要成分。人们普遍认为 Tau 的磷酸化程度是蛋白激酶和磷酸酶活性平衡的结果。这两种酶活性之间的平衡被破坏被认为是 Tau 过度磷酸化以及随后的毒性和疾病进展的根源。

目的

我们探讨了这样一种可能性,即除了磷酸酶对磷酸化 Tau 的作用之外,PKA 的催化亚基还可以根据 ATP/ADP 比,催化 Tau 的磷酸化和去磷酸化。

方法

我们使用不同磷酸化形式的 Tau 所经历的相对电泳迁移率的变化,作为酶催化作用的传感器。

结果

结果与 PKA 和许多其他蛋白激酶催化的磷酸化反应(ATP+蛋白=ADP+磷酸化蛋白)的长期已知热力学可逆性一致。

结论

这些结果有助于将神经元的分区化能量状态和线粒体功能障碍置于 Tau 相关病理学的上游。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/7990467/06f523fce57d/jad-79-jad201077-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/7990467/9a13b96670b9/jad-79-jad201077-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/7990467/4ff815958b9d/jad-79-jad201077-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/7990467/372a312cbf70/jad-79-jad201077-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/7990467/9398415f6614/jad-79-jad201077-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/7990467/f614b3045b9b/jad-79-jad201077-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/7990467/0ea6eedf4d46/jad-79-jad201077-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/7990467/6431826b9ff7/jad-79-jad201077-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/7990467/86c61628d764/jad-79-jad201077-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/7990467/06f523fce57d/jad-79-jad201077-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/7990467/9a13b96670b9/jad-79-jad201077-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/7990467/4ff815958b9d/jad-79-jad201077-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/7990467/372a312cbf70/jad-79-jad201077-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/7990467/9398415f6614/jad-79-jad201077-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/7990467/f614b3045b9b/jad-79-jad201077-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/7990467/0ea6eedf4d46/jad-79-jad201077-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/7990467/6431826b9ff7/jad-79-jad201077-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/7990467/86c61628d764/jad-79-jad201077-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a2/7990467/06f523fce57d/jad-79-jad201077-g009.jpg

相似文献

1
Phosphorylation and Dephosphorylation of Tau Protein by the Catalytic Subunit of PKA, as Probed by Electrophoretic Mobility Retard.蛋白激酶 A 的催化亚基对 Tau 蛋白的磷酸化和去磷酸化作用的电泳迁移率变化探测
J Alzheimers Dis. 2021;79(3):1143-1156. doi: 10.3233/JAD-201077.
2
Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.参与阿尔茨海默病神经纤维变性的激酶、磷酸酶及tau位点。
Eur J Neurosci. 2007 Jan;25(1):59-68. doi: 10.1111/j.1460-9568.2006.05226.x.
3
Phosphorylation of tau by cyclic-AMP-dependent protein kinase.环磷酸腺苷依赖性蛋白激酶对tau蛋白的磷酸化作用。
Dementia. 1993 Sep-Oct;4(5):256-63. doi: 10.1159/000107331.
4
Okadaic acid enhances abnormal phosphorylation on tau proteins.冈田酸会增强tau蛋白的异常磷酸化。
Neurosci Lett. 1993 Jun 25;156(1-2):67-9. doi: 10.1016/0304-3940(93)90441-m.
5
Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A.蛋白磷酸酶2A对阿尔茨海默病异常磷酸化tau蛋白的去磷酸化作用
Neuroscience. 1994 Aug;61(4):765-72. doi: 10.1016/0306-4522(94)90400-6.
6
Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants.微管相关激酶对人tau蛋白的磷酸化作用:糖原合成酶激酶3β和周期蛋白依赖性激酶5是关键参与者。
J Neurosci Res. 2000 Nov 1;62(3):463-72. doi: 10.1002/1097-4547(20001101)62:3<463::AID-JNR16>3.0.CO;2-7.
7
Tau therapeutic strategies for the treatment of Alzheimer's disease.用于治疗阿尔茨海默病的tau蛋白治疗策略。
Curr Top Med Chem. 2006;6(6):579-95. doi: 10.2174/156802606776743057.
8
Hyperphosphorylation of human TAU by brain kinase PK40erk beyond phosphorylation by cAMP-dependent PKA: relation to Alzheimer's disease.脑激酶PK40erk对人TAU的磷酸化作用超过了环磷酸腺苷依赖性蛋白激酶A的磷酸化作用:与阿尔茨海默病的关系
Biochem Biophys Res Commun. 1994 Apr 15;200(1):187-94. doi: 10.1006/bbrc.1994.1432.
9
Evidence for cdk5 as a major activity phosphorylating tau protein in porcine brain extract.在猪脑提取物中,细胞周期蛋白依赖性激酶5作为磷酸化tau蛋白的主要活性物质的证据。
J Biochem. 1995 Apr;117(4):741-9. doi: 10.1093/oxfordjournals.jbchem.a124771.
10
Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.使tau蛋白从微管上脱离的磷酸化作用(Ser262、Ser214)也能保护其不聚集成阿尔茨海默病的双螺旋丝。
Biochemistry. 1999 Mar 23;38(12):3549-58. doi: 10.1021/bi981874p.

引用本文的文献

1
The role of probiotics, prebiotics, and postbiotics: cellular and molecular pathways activated on glial cells in Alzheimer's disease.益生菌、益生元及后生元的作用:阿尔茨海默病中胶质细胞激活的细胞及分子途径
Front Neurosci. 2025 Jun 25;19:1598011. doi: 10.3389/fnins.2025.1598011. eCollection 2025.
2
The Role and Pathogenesis of Tau Protein in Alzheimer's Disease.Tau蛋白在阿尔茨海默病中的作用及发病机制
Biomolecules. 2025 Jun 5;15(6):824. doi: 10.3390/biom15060824.
3
Long-term exposure to excessive norepinephrine in the brain induces tau aggregation, neuronal death, and cognitive deficits in early tau transgenic mice.

本文引用的文献

1
Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Related Disorders: From Molecular Mechanisms to Clinical Evidence.与认知衰退相关疾病的线粒体和氧化应激靶向物质:从分子机制到临床证据。
Oxid Med Cell Longev. 2019 May 12;2019:9695412. doi: 10.1155/2019/9695412. eCollection 2019.
2
Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer's disease.阿尔茨海默病患者大脑中特定区域突触线粒体的耗竭。
Acta Neuropathol. 2018 Nov;136(5):747-757. doi: 10.1007/s00401-018-1903-2. Epub 2018 Sep 6.
3
Tau Structures.
长期暴露于大脑中过量的去甲肾上腺素会在早期tau转基因小鼠中诱导tau蛋白聚集、神经元死亡和认知缺陷。
Aging Cell. 2025 Mar;24(3):e14420. doi: 10.1111/acel.14420. Epub 2024 Nov 26.
4
The Expression of Epac2 and GluA3 in an Alzheimer's Disease Experimental Model and Postmortem Patient Samples.Epac2和GluA3在阿尔茨海默病实验模型及死后患者样本中的表达
Biomedicines. 2023 Jul 25;11(8):2096. doi: 10.3390/biomedicines11082096.
5
Elucidation of the GSK3α Structure Informs the Design of Novel, Paralog-Selective Inhibitors.阐明 GSK3α 结构可用于设计新型、选择性针对同工酶的抑制剂。
ACS Chem Neurosci. 2023 Mar 15;14(6):1080-1094. doi: 10.1021/acschemneuro.2c00476. Epub 2023 Feb 22.
tau蛋白结构
Front Aging Neurosci. 2016 Nov 8;8:262. doi: 10.3389/fnagi.2016.00262. eCollection 2016.
4
Reduced number of axonal mitochondria and tau hypophosphorylation in mouse P301L tau knockin neurons.小鼠P301L tau基因敲入神经元中轴突线粒体数量减少及tau蛋白低磷酸化
Neurobiol Dis. 2016 Jan;85:1-10. doi: 10.1016/j.nbd.2015.10.007. Epub 2015 Oct 11.
5
A Phosphorylation-Induced Turn Defines the Alzheimer's Disease AT8 Antibody Epitope on the Tau Protein.磷酸化诱导的构象变化决定了 Tau 蛋白上阿尔茨海默病 AT8 抗体的抗原表位。
Angew Chem Int Ed Engl. 2015 Jun 1;54(23):6819-23. doi: 10.1002/anie.201501898. Epub 2015 Apr 16.
6
Oligomer formation of tau protein hyperphosphorylated in cells.细胞中过度磷酸化的tau蛋白的寡聚体形成。
J Biol Chem. 2014 Dec 5;289(49):34389-407. doi: 10.1074/jbc.M114.611368. Epub 2014 Oct 22.
7
On the dynamics of the adenylate energy system: homeorhesis vs homeostasis.论腺苷酸能量系统的动力学:动态平衡与稳态平衡
PLoS One. 2014 Oct 10;9(10):e108676. doi: 10.1371/journal.pone.0108676. eCollection 2014.
8
Characterization of tau oligomeric seeds in progressive supranuclear palsy.在进行性核上性麻痹中 tau 寡聚体种子的特征。
Acta Neuropathol Commun. 2014 Jun 14;2:73. doi: 10.1186/2051-5960-2-73.
9
Physiological release of endogenous tau is stimulated by neuronal activity.内源性 tau 的生理释放受神经元活动的刺激。
EMBO Rep. 2013 Apr;14(4):389-94. doi: 10.1038/embor.2013.15. Epub 2013 Feb 15.
10
NIH Image to ImageJ: 25 years of image analysis.NIH 图像到 ImageJ:25 年的图像分析。
Nat Methods. 2012 Jul;9(7):671-5. doi: 10.1038/nmeth.2089.